Phio Pharmaceuticals
PHIO
#10301
Rank
HK$89.51 M
Marketcap
HK$8.11
Share price
-3.70%
Change (1 day)
-58.01%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -HK$62.01 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$55.75 Million, an increase over its 2023 earnings that were of -HK$84.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$62.01 Million11.23%
2024 -HK$55.75 Million-33.96%
2023 -HK$84.41 Million-5.7%
2022 -HK$89.5 Million-13.6%
2021 -HK$0.11 Billion51.09%
2020 -HK$68.56 Million-1.28%
2019 -HK$69.45 Million21.03%
2018 -HK$57.38 Million-53.1%
2017 -HK$0.13 Billion74.49%
2016 -HK$70.12 Million-12.02%
2015 -HK$79.7 Million16.17%
2014 -HK$68.61 Million-57.95%
2013 -HK$0.17 Billion62.45%
2012 -HK$0.11 Billion0.87%
2011 -HK$99.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion 128.29%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion 1,905.27%๐Ÿ‡บ๐Ÿ‡ธ USA